KILL New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)

 

Genentech requests that their press release NewsItemId: 20240125093104 “New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)” be killed.

The release was issued prematurely by Genentech.

A replacement release will be issued at a later date.

Contacts

Media Contact:

Shirley Dang, (650) 467-6800

Advocacy Contact:

Danielle Haney, (240) 805-4810

Investor Contacts:

Loren Kalm, (650) 225-3217

Bruno Eschli, +41 61 687 5284

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
+0.00 (0.00%)
AAPL  277.55
+0.00 (0.00%)
AMD  214.10
-0.14 (-0.07%)
BAC  52.99
+0.00 (0.00%)
GOOG  320.28
+0.00 (0.00%)
META  633.61
+0.00 (0.00%)
MSFT  485.50
+0.00 (0.00%)
NVDA  180.26
+0.00 (0.00%)
ORCL  204.96
+0.00 (0.00%)
TSLA  426.58
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.